209 related articles for article (PubMed ID: 17070155)
1. Comparison between drug-eluting stents and beta-radiation for the treatment of diffuse in-stent restenosis: clinical and angiographic outcomes.
Zavalloni D; Belli G; Rossi ML; Scatturin M; Morenghi E; Catalano G; Tosi G; Gasparini GL; Pagnotta P; Presbitero P
Am Heart J; 2006 Nov; 152(5):908.e1-7. PubMed ID: 17070155
[TBL] [Abstract][Full Text] [Related]
2. Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.
Iofina E; Radke PW; Skurzewski P; Haager PK; Blindt R; Koch KC; Hanrath P; vom Dahl J; Hoffmann R
Heart; 2005 Dec; 91(12):1584-9. PubMed ID: 15797938
[TBL] [Abstract][Full Text] [Related]
3. Intracoronary brachytherapy following drug-eluting stent failure. It's still not time to hang up the spikes!
Angiolillo DJ; Sabaté M; Jiménez-Quevedo P; Alfonso F; Galván C; Fernández JM; Hernandez-Antolin R; Escaned J; Bañuelos C; Moreno R; Macaya C
Cardiovasc Radiat Med; 2003; 4(4):171-5. PubMed ID: 15321053
[TBL] [Abstract][Full Text] [Related]
4. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis.
Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D
Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting stents versus repeat vascular brachytherapy for patients with recurrent in-stent restenosis after failed intracoronary radiation.
Chu WW; Torguson R; Pichard AD; Satler LF; Chan R; Porrazzo M; Kent KM; Suddath WO; Waksman R
J Invasive Cardiol; 2005 Dec; 17(12):659-62. PubMed ID: 16327049
[TBL] [Abstract][Full Text] [Related]
6. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
[TBL] [Abstract][Full Text] [Related]
7. A comparison of angiographic and clinical outcomes after sirolimus-eluting versus paclitaxel-eluting stents for the treatment of in-stent restenosis.
Li JJ; Xu B; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2006 Jul; 119(13):1059-64. PubMed ID: 16834923
[TBL] [Abstract][Full Text] [Related]
8. Intravascular brachytherapy versus drug-eluting stents for the treatment of patients with drug-eluting stent restenosis.
Torguson R; Sabate M; Deible R; Smith K; Chu WW; Kent KM; Pichard AD; Suddath WO; Satler LF; Waksman R
Am J Cardiol; 2006 Nov; 98(10):1340-4. PubMed ID: 17134625
[TBL] [Abstract][Full Text] [Related]
9. Late results (>10 years) of intracoronary beta brachytherapy for diffuse in-stent restenosis.
Seabra Gomes R; de Araújo Gonçalves P; Campante Teles R; de Sousa Almeida M
Rev Port Cardiol; 2014 Oct; 33(10):609-16. PubMed ID: 25304770
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
[TBL] [Abstract][Full Text] [Related]
11. Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound.
Schiele TM; König A; Rieber J; Erhard I; Leibig M; Theisen K; Siebert U; Klauss V
Am Heart J; 2005 Aug; 150(2):351-7. PubMed ID: 16086942
[TBL] [Abstract][Full Text] [Related]
12. Comparison between sirolimus-eluting stents and intracoronary catheter-based beta radiation for the treatment of in-stent restenosis.
Feres F; Muñoz JS; Abizaid A; Albertal M; Mintz GS; Staico R; Centemero M; Mattos LA; Maldonado G; Tanajura LF; Chaves A; Pinto I; Abizaid AS; Seixas AC; Vaz VD; Sousa A; Sousa JE
Am J Cardiol; 2005 Dec; 96(12):1656-62. PubMed ID: 16360353
[TBL] [Abstract][Full Text] [Related]
13. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: the same or a different stent.
Cosgrave J; Melzi G; Corbett S; Biondi-Zoccai GG; Babic R; Airoldi F; Chieffo A; Sangiorgi GM; Montorfano M; Michev I; Carlino M; Colombo A
Am Heart J; 2007 Mar; 153(3):354-9. PubMed ID: 17307411
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
[TBL] [Abstract][Full Text] [Related]
15. Poor outcome in patients treated with brachytherapy for diffuse in-stent restenosis. The role of additional stenting despite prolonged antiplatelet therapy.
Zavalloni D; Rossi M; Belli G; Scatturin M; Morenghi E; Marsico F; Catalano G; Tosi G; Pagnotta P; Presbitero P
J Invasive Cardiol; 2005 Nov; 17(11):598-602. PubMed ID: 16264205
[TBL] [Abstract][Full Text] [Related]
16. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent.
Garg S; Smith K; Torguson R; Okabe T; Slottow TL; Steinberg DH; Roy P; Xue Z; Gevorkian N; Satler LF; Kent KM; Suddath WO; Pichard AD; Waksman R
Catheter Cardiovasc Interv; 2007 Jul; 70(1):9-14. PubMed ID: 17580367
[TBL] [Abstract][Full Text] [Related]
17. Comparison of angiographic patterns of in-stent restenosis between sirolimus- and paclitaxel-eluting stent.
Park CB; Hong MK; Kim YH; Park DW; Han KH; Lee CW; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2007 Sep; 120(3):387-90. PubMed ID: 17291608
[TBL] [Abstract][Full Text] [Related]
18. Comparison of six-month angiographic and three-year outcomes after sirolimus-eluting stent implantation versus brachytherapy for bare metal in-stent restenosis.
Lee SW; Park SW; Park DW; Lee SW; Kim SH; Jang JS; Jeong YH; Kim YH; Lee CW; Hong MK; Yun SC; Kim JJ; Park SJ
Am J Cardiol; 2007 Aug; 100(3):425-30. PubMed ID: 17659922
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes for sirolimus-eluting stent implantation and vascular brachytherapy for the treatment of in-stent restenosis.
Saia F; Lemos PA; Hoye A; Sianos G; Arampatzis CA; de Feyter PJ; van der Giessen WJ; Smits PC; van Domburg RT; Serruys PW
Catheter Cardiovasc Interv; 2004 Jul; 62(3):283-8. PubMed ID: 15224289
[TBL] [Abstract][Full Text] [Related]
20. Predictor of subsequent target lesion revascularization in patients with drug-eluting stent restenosis undergoing percutaneous coronary intervention.
Takasawa Y; Iijima R; Shiba M; Nakamura M; Sugi K
J Cardiol; 2010 May; 55(3):391-6. PubMed ID: 20350511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
